Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 10Lymphoma, Mantle-Cell 8Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Lymphoma, Non-Hodgkin 6Lymphoma, Large-Cell, Immunoblastic 6Hodgkin Disease 6Burkitt Lymphoma 6Unspecified Adult Solid Tumor, Protocol Specific 5Sezary Syndrome 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Mycosis Fungoides 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, Large-Cell, Anaplastic 5Breast Neoplasms 5Waldenstrom Macroglobulinemia 4Prostatic Neoplasms 4Multiple Myeloma 4Melanoma 4Lung Neoplasms 4Leukemia 4Immunoblastic Lymphadenopathy 4Carcinoma, Non-Small-Cell Lung 4Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Kidney Neoplasms 3Carcinoma, Renal Cell 3Blast Crisis 3

Interventions

Doxorubicin 25Radiotherapy 16Ifosfamide 14Trabectedin 10pazopanib 6ribociclib 5pembrolizumab 5Specimen Handling 5Magnetic Resonance Spectroscopy 5Gemcitabine 5Biopsy 5palbociclib 4Radiation 4Docetaxel 4Chemotherapy, Adjuvant 4selinexor 3liposomal doxorubicin 3eribulin 3abemaciclib 3X-Rays 3Vincristine 3Neoadjuvant Therapy 3Imatinib Mesylate 3Filgrastim 3Etoposide 3Cyclophosphamide 3toripalimab 2temsirolimus 2romidepsin 2pegfilgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Liposarcoma × tanespimycin × Clear all
NCT00969917 2015-04-14

Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma

Infinity Pharmaceuticals, Inc.

Phase 2 Withdrawn
Sarcoma

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡